SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

Share Price is delayed by 15 minutes
Get Live Data
443.00    10.00 (2.31%)
Bid:
440.00
Ask:
443.00
Spread: 3.00 (0.682%)
Market Cap: £218.72m
CLIG Live PriceLast checked at - London Stock Exchange

Intraday City Lon Inv Share Chart

Interim Management Statement

8 Oct 2015 07:00

RNS Number : 5957B
City of London Investment Group PLC
08 October 2015
 



CITY OF LONDON INVESTMENT GROUP PLC

("City of London", "the Company" or "the Group")

Trading Update - 1st Quarter Funds under management (FuM)

City of London (LSE: CLIG), a leading emerging markets asset management group, announces that as at 30th September 2015, FuM were US$3.6 billion (£2.4 billion). This compares with US$4.2 billion (£2.7 billion) at the Company's year-end on 30th June 2015. In US dollar terms, this represents a fall of c14% compared to the MSCI Emerging Markets Index (US dollar based), which fell by c18% over the same period.

Despite the recent market volatility, the Board is encouraged by the diversity in the current pipeline of potential mandates, with c$750 million spread across EM, Frontier, Developed and Tactical Asset Allocation asset classes. As a result the Company is hopeful that at least a net $250 million of additional FuM should be achievable over the next 6-9 months.

Monthly updates of FuM are available on our website -www.citlon.co.uk.

Operations

The Group's income currently accrues at a weighted average rate of approximately 85 basis points, net of third party commissions. "Fixed" costs for the quarter were a little over £0.8 million per month, and accordingly the current run-rate for operating profit, before profit-share at 30%, is approximately £0.8 million per month based upon current FuM and a US$/£ exchange rate of US$1.52 to £1. The Group estimates that the post-tax profit for the first three months of the year will be approximately £1.2 million, after an unrealised loss on seed investments of £0.2 million.

Appropriate steps are being taken to reduce the firm's overhead.

Having provided shareholders with both a template and assumptions via which they can determine their own estimate of CLIG's profitability, shareholders can accordingly adjust their estimates based on the recent fall in markets.

Dividends

The final dividend of 16 pence per share, subject to approval at the AGM on 19th October, will be paid on 30th October 2015, bringing the total dividend for the financial year 2014-15 to 24 pence.

Investor afternoon

Shareholders and other interested parties are invited to attend our investor afternoon starting at 3pm on 19th October at the offices of Canaccord Genuity Limited, 88 Wood Street, London EC2V 7QR.

Presentations will include: Managing the P&L through a difficult market environment, Core values, EM CEF strategy, EM-What could go right?, Diversification CEF strategies and US marketing initiatives.

If you would like to attend then please email investorrelations@citlon.co.uk as spaces are limited.

 

For further information please visit www.citlon.co.uk or contact:

Barry Olliff (CEO)

City of London Investment Group PLC

Tel: 001 215 313 3774

 

Roger Lambert

Canaccord Genuity Limited

Financial Adviser & Broker

Tel: +44 (0)20 7523 8000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDMMGGVNKGKZM
Date   Source Headline
4th Jan 20169:55 amRNSBlocklisting Interim Review
31st Dec 201512:40 pmRNSSecond Price Monitoring Extn
31st Dec 201512:35 pmRNSPrice Monitoring Extension
15th Dec 201510:41 amRNSShare Buy Back
30th Nov 20152:27 pmRNSHolding(s) in Company
10th Nov 20154:31 pmRNSDirector/PDMR Shareholding
21st Oct 20154:52 pmRNSPDMR Share Holding/Share Buy Back
20th Oct 20154:05 pmRNSHardman & Co issues research report
19th Oct 20154:36 pmRNSResult of AGM
19th Oct 20157:00 amRNSAGM Trading Update
8th Oct 20156:01 pmRNSHardman & Co issues research
8th Oct 20157:00 amRNSInterim Management Statement
15th Sep 201511:18 amRNSHardman & Co issues research report
14th Sep 20157:00 amRNSFinal Results
1st Sep 20154:35 pmRNSPrice Monitoring Extension
28th Aug 201512:04 pmRNSText of letter to icapital.biz Berhad
25th Aug 20157:00 amRNSDividend Timetable
21st Aug 20157:00 amRNSBoard Changes
16th Jul 20153:08 pmRNSHardman & Co issues research report
15th Jul 20157:00 amRNSTrading Update
2nd Jul 20153:56 pmRNSBlocklisting Interim Review
19th Jun 20154:07 pmRNSDirector/PDMR Shareholding
17th Apr 20153:03 pmRNSDirector/PDMR Shareholding
8th Apr 20157:00 amRNSInterim Management Statement
18th Feb 20154:58 pmRNSDirector/PDMR Shareholding
11th Feb 20157:00 amRNSInterim Results
6th Jan 20157:00 amRNSFUNDS UNDER MANAGEMENT AT 31/12/14 TRADING UPDATE
2nd Jan 20157:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
19th Dec 201410:56 amRNSHolding(s) in Company
12th Dec 20149:15 amRNSShare Buyback and Total Voting Rights
11th Dec 20149:18 amRNSShare Buyback and Total Voting Rights
13th Nov 20143:43 pmRNSShare Buyback and Total Voting Rights
3rd Nov 20148:54 amRNSShare Buy Back and Total Voting Rights
22nd Oct 20145:17 pmRNSResult of AGM
22nd Oct 20147:00 amRNSInterim Management Statement
8th Oct 20149:14 amRNSHolding(s) in Company
15th Sep 20147:00 amRNSFinal Results
15th Jul 20147:00 amRNSTrading Update
1st Jul 20147:00 amRNSBlocklisting Interim Review
22nd May 20144:35 pmRNSPrice Monitoring Extension
25th Apr 20145:06 pmRNSHolding(s) in Company
5th Mar 201411:41 amRNSDirector/PDMR Shareholding
4th Mar 20147:00 amRNSQuarterly Funds under Management ("FuM") Update
20th Jan 20147:00 amRNSHalf Yearly Results
2nd Jan 20142:13 pmRNSBlocklisting Interim Review
2nd Dec 20137:00 amRNSTrading Update
8th Oct 20134:10 pmRNSResult of AGM
7th Oct 20137:00 amRNSInterim Management Statement
13th Sep 201310:02 amRNSHolding(s) in Company
12th Sep 201310:48 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.